• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

有症状人群粪便免疫化学检测的障碍与促进因素:一项快速系统的范围综述和差距分析。

Barriers and facilitators to faecal immunochemical testing in symptomatic populations: A rapid systematic scoping review and gap analysis.

作者信息

Hamer-Kiwacz Sienna, Berntsson Hannah, Galloway George, Tran Ann-Marie, Tan Jia Yun, Hind Daniel, Kurien Matthew

机构信息

Division of Population Health, School of Medicine and Population Health, The University of Sheffield, Sheffield, UK.

The Medical School, The University of Sheffield, Sheffield, UK.

出版信息

J Eval Clin Pract. 2025 Mar;31(2):e14120. doi: 10.1111/jep.14120. Epub 2024 Sep 18.

DOI:10.1111/jep.14120
PMID:39291807
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11938400/
Abstract

AIM

Faecal immunochemical testing (FIT) is used to triage people with signs or symptoms of a colorectal cancer (CRC). Recent guidelines have recommended further research to improve access, uptake and return of FIT. This systematic scoping review aims to understand the barriers and facilitators to FIT testing in symptomatic patients.

METHOD

Qualitative, quantitative and mixed-methods studies published after September 2013 were included. MEDLINE, EMBASE and PsycINFO databases were searched to identify publications examining barriers and facilitators to FIT. Initially, the data underwent thematic analysis, and subsequently, factors were aligned to components of the Capability, Opportunity, Motivation, Behaviour model. All outcomes are presented in adherence to the Preferred Reporting Items for Systematic Reviews and Meta-Analyses guidelines.

RESULTS

One thousand two hundred thirty-two papers were identified; 11 met the inclusion criteria. Barriers and facilitators were identified at the patient (e.g., knowledge), provider (e.g., general practitioner awareness) and service level (e.g., method of providing FIT kits). Factors were categorised into the subcomponents of the model: psychological capability (e.g., lack of FIT knowledge), reflective motivation (e.g., beliefs regarding FIT sampling and faeces being unhygienic) and automatic motivation (e.g., embarrassment, scary, anxiety provoking). Gaps in knowledge emerged in three domains: (1) patient experience, (2) FIT pathway and (3) healthcare professionals experience of FIT.

CONCLUSION

This systematic scoping review provides a summary of the literature on FIT uptake, and identified factors across multiple levels and components. To increase adherence to FIT completion within primary care, a multifaceted theory and evidence-based approach is needed to underpin future behavioural science interventions.

摘要

目的

粪便免疫化学检测(FIT)用于对有结直肠癌(CRC)体征或症状的人群进行分流。近期指南建议开展进一步研究,以改善FIT检测的可及性、接受度和检测结果反馈情况。本系统综述旨在了解有症状患者进行FIT检测的障碍和促进因素。

方法

纳入2013年9月之后发表的定性、定量及混合方法研究。检索MEDLINE、EMBASE和PsycINFO数据库,以识别研究FIT检测障碍和促进因素的出版物。首先,对数据进行主题分析,随后将因素与“能力、机会、动机、行为”模型的各个组成部分进行匹配。所有结果均按照系统评价和Meta分析的首选报告项目指南呈现。

结果

共识别出1232篇论文;11篇符合纳入标准。在患者层面(如知识水平)、医疗服务提供者层面(如全科医生认知度)和服务层面(如提供FIT检测试剂盒的方式)均识别出了障碍和促进因素。这些因素被归类到模型的子成分中:心理能力(如缺乏FIT知识)、反思性动机(如对FIT样本采集以及粪便不卫生的看法)和自动性动机(如尴尬、可怕、引发焦虑)。在三个领域出现了知识缺口:(1)患者体验,(2)FIT检测流程,(3)医疗保健专业人员对FIT检测的体验。

结论

本系统综述总结了关于FIT检测接受情况的文献,并识别出了多个层面和组成部分的因素。为提高初级保健中FIT检测的完成率,需要一种多方面的基于理论和证据的方法来支持未来的行为科学干预措施。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1ae9/11938400/8588ff7e3542/JEP-31-0-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1ae9/11938400/8588ff7e3542/JEP-31-0-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1ae9/11938400/8588ff7e3542/JEP-31-0-g001.jpg

相似文献

1
Barriers and facilitators to faecal immunochemical testing in symptomatic populations: A rapid systematic scoping review and gap analysis.有症状人群粪便免疫化学检测的障碍与促进因素:一项快速系统的范围综述和差距分析。
J Eval Clin Pract. 2025 Mar;31(2):e14120. doi: 10.1111/jep.14120. Epub 2024 Sep 18.
2
Application of the COM-B model to barriers and facilitators to chlamydia testing in general practice for young people and primary care practitioners: a systematic review.运用 COM-B 模型分析在年轻人和初级保健医生中进行衣原体检测的一般实践中的障碍和促进因素:系统评价。
Implement Sci. 2018 Oct 22;13(1):130. doi: 10.1186/s13012-018-0821-y.
3
Beyond the black stump: rapid reviews of health research issues affecting regional, rural and remote Australia.超越黑木树:影响澳大利亚地区、农村和偏远地区的健康研究问题的快速综述。
Med J Aust. 2020 Dec;213 Suppl 11:S3-S32.e1. doi: 10.5694/mja2.50881.
4
Barriers and facilitators of implementing a multicomponent intervention to improve faecal immunochemical test (FIT) colorectal cancer screening in primary care clinics, Alberta.在艾伯塔省的基层医疗诊所实施多组分干预措施以改善粪便免疫化学试验(FIT)结直肠癌筛查的障碍和促进因素。
BMJ Open Qual. 2024 May 27;13(2):e002686. doi: 10.1136/bmjoq-2023-002686.
5
Barriers and facilitators of benzathine penicillin G adherence among rheumatic heart disease patients: a mixed methods systematic review using the COM-B (capability, opportunity, and motivation for behavior) model.风湿性心脏病患者苄星青霉素G依从性的障碍与促进因素:一项使用COM-B(行为能力、机会和动机)模型的混合方法系统评价
Syst Rev. 2024 Dec 3;13(1):297. doi: 10.1186/s13643-024-02691-1.
6
Faecal immunochemical tests to triage patients with lower abdominal symptoms for suspected colorectal cancer referrals in primary care: a systematic review and cost-effectiveness analysis.粪便免疫化学检测用于在初级保健中对有下腹部症状的患者进行分流,以确定是否需要转诊疑似结直肠癌患者:一项系统评价和成本效益分析。
Health Technol Assess. 2017 May;21(33):1-234. doi: 10.3310/hta21330.
7
Strategies used for childhood chronic functional constipation: the SUCCESS evidence synthesis.用于儿童慢性功能性便秘的策略:SUCCESS 证据综合。
Health Technol Assess. 2024 Jan;28(5):1-266. doi: 10.3310/PLTR9622.
8
High-risk symptoms and quantitative faecal immunochemical test accuracy: Systematic review and meta-analysis.高危症状与定量粪便免疫化学检测的准确性:系统评价和荟萃分析。
World J Gastroenterol. 2019 May 21;25(19):2383-2401. doi: 10.3748/wjg.v25.i19.2383.
9
Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.在流行地区,服用抗叶酸抗疟药物的人群中,叶酸补充剂与疟疾易感性和严重程度的关系。
Cochrane Database Syst Rev. 2022 Feb 1;2(2022):CD014217. doi: 10.1002/14651858.CD014217.
10
A systematic review of clinic and community intervention to increase fecal testing for colorectal cancer in rural and low-income populations in the United States - How, what and when?美国农村和低收入人群结直肠癌粪便检测的临床和社区干预的系统评价 - 如何、什么和何时?
BMC Cancer. 2018 Jan 6;18(1):40. doi: 10.1186/s12885-017-3813-4.

本文引用的文献

1
Assessing unConventional Evidence (ACE) tool: development and content of a tool to assess the strengths and limitations of 'unconventional' source materials.评估非常规证据(ACE)工具:开发和内容评估“非常规”来源材料的优势和局限性的工具。
Health Res Policy Syst. 2024 Jan 2;22(1):2. doi: 10.1186/s12961-023-01080-9.
2
Colorectal cancer in symptomatic patients: How to improve the diagnostic pathway.症状性患者的结直肠癌:如何改善诊断途径。
Best Pract Res Clin Gastroenterol. 2023 Oct;66:101842. doi: 10.1016/j.bpg.2023.101842. Epub 2023 Jun 21.
3
Sociodemographic variations in the uptake of faecal immunochemical tests in primary care: a retrospective study.
社会人口统计学因素对初级保健中粪便免疫化学检测接受率的影响:一项回顾性研究。
Br J Gen Pract. 2023 Oct 26;73(736):e843-e849. doi: 10.3399/BJGP.2023.0033. Print 2023 Nov.
4
Faecal immunochemical testing in symptomatic lower gastrointestinal triage: cohort study of patient acceptability and impact of social deprivation.有症状的下消化道分诊中的粪便免疫化学检测:患者可接受性及社会剥夺影响的队列研究
Br J Surg. 2023 Mar 30;110(4):511-512. doi: 10.1093/bjs/znad036.
5
Patient experience and satisfaction with symptomatic faecal immunochemical testing: an explanatory sequential mixed-methods evaluation.患者对症状性粪便免疫化学检测的体验和满意度:一项解释性序贯混合方法评估。
Br J Gen Pract. 2023 Jan 26;73(727):e104-e114. doi: 10.3399/BJGP.2022.0241. Print 2023 Feb.
6
Who are the patients being offered the faecal immunochemical test in routine English general practice, and for what symptoms? A prospective descriptive study.在常规英国家庭医疗实践中,哪些患者接受粪便免疫化学检测,针对哪些症状?一项前瞻性描述性研究。
BMJ Open. 2022 Sep 19;12(9):e066051. doi: 10.1136/bmjopen-2022-066051.
7
Healthcare Professional and Patient Perceptions of Changes in Colorectal Cancer Care Delivery During the COVID-19 Pandemic and Impact on Health Inequalities.医疗保健专业人员和患者对 COVID-19 大流行期间结直肠癌护理提供方式变化的看法及其对健康不平等的影响。
Cancer Control. 2022 Jan-Dec;29:10732748221114615. doi: 10.1177/10732748221114615.
8
Faecal immunochemical testing (FIT) in patients with signs or symptoms of suspected colorectal cancer (CRC): a joint guideline from the Association of Coloproctology of Great Britain and Ireland (ACPGBI) and the British Society of Gastroenterology (BSG).疑似结直肠癌(CRC)体征或症状患者的粪便免疫化学检测(FIT):英国和爱尔兰结直肠外科学会(ACPGBI)与英国胃肠病学会(BSG)联合指南
Gut. 2022 Jul 12;71(10):1939-62. doi: 10.1136/gutjnl-2022-327985.
9
Patient-reported outcome measures show FIT as an acceptable investigation to rule out colorectal cancer in the two-week wait cohort.患者报告结局测量显示,在两周等待队列中,FIT 是一种可接受的排除结直肠癌的检查方法。
Ann R Coll Surg Engl. 2023 Apr;105(4):336-341. doi: 10.1308/rcsann.2022.0025. Epub 2022 May 31.
10
Faecal immunochemical test for suspected colorectal cancer symptoms: patient survey of usability and acceptability.针对疑似结直肠癌症状的粪便免疫化学检测:患者对可用性和可接受性的调查
BJGP Open. 2022 Mar 22;6(1). doi: 10.3399/BJGPO.2021.0102. Print 2022 Mar.